[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354251-105":59,"doc-detail-354251-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","germline-predisposition-in-pediatric-central-nervous-system-tumors-insights-from-a-multigene-panel-study","Germline Predisposition in Pediatric Central Nervous System Tumors - Insights from a Multigene Panel Study","","Germline variants in cancer predisposition genes are increasingly recognized in pediatric cancers, yet their spectrum in East Asian children with central nervous system (CNS) tumors remains incompletely characterized. This targeted study assessed the prevalence and clinical relevance of pathogenic or likely pathogenic (P/LP) germline mutations in Korean children, adolescents, and young adults with CNS tumors. Peripheral blood DNA from 108 patients was analyzed by next-generation sequencing of 358 cancer-associated genes using ACMG/AMP classification, ClinVar, and curated literature, identifying 15.7% with P/LP variants and highlighting molecular heterogeneity and the need for germline testing for risk assessment and surveillance.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/germline-predisposition-in-pediatric-central-nervous-system-tumors-insights-from-a-multigene-panel-study/354251/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/germline-predisposition-in-pediatric-central-nervous-system-tumors-insights-from-a-multigene-panel-study/354251.png","ImageObject",300,407,{"name":92,"@type":93},"McQueen","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-22","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main objective of the study?","Question",{"text":112,"@type":113},"To determine the prevalence and clinical significance of germline cancer-related gene alterations in Korean children, adolescents, and young adults with CNS tumors.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was germline alteration testing performed?",{"text":117,"@type":113},"Peripheral blood DNA from 108 patients underwent targeted next-generation sequencing of 358 cancer-associated genes, with germline variants classified using ACMG/AMP guidelines and curated using ClinVar and relevant literature.",{"name":119,"@type":110,"acceptedAnswer":120},"What proportion of patients carried pathogenic or likely pathogenic germline variants?",{"text":121,"@type":113},"Among 108 patients, 17 (15.7%) carried pathogenic or likely pathogenic (P/LP) germline variants, with the highest frequency observed in other CNS tumors and gliomas.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354251,1790498831,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","[http://doi.org/10.32604/or.2026.079120](http://doi.org/10.32604/or.2026.079120)  \nARTICLE  \nGermline Predisposition in Pediatric Central Nervous System Tumors: Insights from a Multigene Panel Study  \nMeerim Park 1 , Seungman Park2 , Ensel Oh3 , Jongmun Choi4 , Mi Mi Kwon 1 , Seog-Yun Park5 , Jun Ah Lee 1 and Hyeon Jin Park 1, *  \n1Department of Pediatrics, Center for Pediatric Cancer, National Cancer Center, Goyang, Republic of Korea  \n2Department of Laboratory Medicine, National Cancer Center, Goyang, Republic of Korea  \n3 Geninus Inc., BI Center, Seoul, Republic of Korea  \n4NGS Research Center, Seegene Medical Foundation, Seoul, Republic of Korea  \n5Department of Pathology, National Cancer Center, Goyang, Republic of Korea  \n*[Corresponding Author: Hyeon Jin Park. Email: hjpark@ncc.re.kr](Corresponding Author: Hyeon Jin Park. Email: hjpark@ncc.re.kr)  \n[Received: 15 January 2026](Received: 15 January 2026); [Accepted: 30 March 2026](Accepted: 30 March 2026); [Published: 21 May 2026](Published: 21 May 2026)  \nABSTRACT: Objectives: Germline variants in cancer predisposition genes have been increasingly recognized in pediatric cancers. However, their spectrum in East Asian children with central nervous system (CNS) tumors remains insufficiently defined. This study investigated the prevalence and clinical significance of pathogenic or likely pathogenic (P/LP) germline mutations in Korean children, adolescents, and young adults (AYAs) with CNS tumors. Methods: We performed targeted next-generation sequencing of 358 cancer-associated genes using peripheral blood DNA from 108 patients. Germline variants were classified according to ACMG/AMP guidelines and curated using ClinVar and relevant literature. Results: Among 108 patients, 17 (15.7%) carried P/LP germline variants. The median age at diagnosis was 7.7 years (range, 1.0–24.0), and 64.7% were male. P/LP variants were most frequent in other CNS tumors (4/11, 36.4%), including 2 glioneuronal tumors, 1 schwannoma, 1 atypical teratoid rhabdoid tumor (ATRT), and gliomas (9/32, 28.1%), followed by medulloblastomas (3/31, 9.7%) . In gliomas, P/LP variants in MLH1, NF1, MUTYH, PALB2, PMS2, FANCM, and TP53 were observed, while medulloblastomas carried alterations in SUFU, BRIP1, and FANCI. SMARCB1 variant was found in ATRT. Among 25 patients with intracranial germ cell tumors, only a single case carried a P/LP germline variant, identified in FANCI. Conclusion: Germline P/LP mutations were identified in 15.7% of Korean children and AYAs with CNS tumors, most commonly in gliomas and other CNS tumors. Our findings highlight the molecular heterogeneity of germline predisposition in CNS tumors and emphasize the importance of germline testing for risk assessment and surveillance.  \nKEYWORDS: Central nervous system (CNS) tumor; children, adolescents, and young adults (AYAs); germline variants; next-generation sequencing  \n1 Introduction  \nPediatric central nervous system (CNS) tumors are the second most common pediatric malignancy after leukemia and form a heterogeneous group of tumors. Pathogenic/likely pathogenic (P/LP) germline mutations in cancer predisposition genes have been shown to be present in 8.5% of children with newly diagnosed cancer [1] . Germline variants in cancer predisposition genes are found in approximately 8–23% of pediatric CNS tumor patients, depending on the cohort and gene panel used [2–5] . Germline variants are identified more frequently in particular tumor types such as atypical teratoid/rhabdoid tumors (ATRTs) and  \nCopyright © 2026 The Authors. Published by Tech Science Press. This work is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.  \nchoroid plexus carcinomas [5] . However, the genetic background of predisposition for the development of pediatric CNS tumors has been insufficiently characterized compared to othe","cbCaidY0gYX2d400","https://ap.wps.com/l/cbCaidY0gYX2d400","pdf",1282480,13,"English","# Abstract\n# Introduction\n# Materials and Methods\n## Patients","[{\"question\":\"What was the main objective of the study?\",\"answer\":\"To determine the prevalence and clinical significance of germline cancer-related gene alterations in Korean children, adolescents, and young adults with CNS tumors.\"},{\"question\":\"How was germline alteration testing performed?\",\"answer\":\"Peripheral blood DNA from 108 patients underwent targeted next-generation sequencing of 358 cancer-associated genes, with germline variants classified using ACMG/AMP guidelines and curated using ClinVar and relevant literature.\"},{\"question\":\"What proportion of patients carried pathogenic or likely pathogenic germline variants?\",\"answer\":\"Among 108 patients, 17 (15.7%) carried pathogenic or likely pathogenic (P/LP) germline variants, with the highest frequency observed in other CNS tumors and gliomas.\"}]","Germline Predisposition in Pediatric Central Nervous System Tumors - Insights from a Multigene Panel Study | PDF",1790109729,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11f5d8b1fba48f17bca96159f079a729.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7fe2cfc4d994be1ff03f2bccff15e9aa.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/511e0e8cbc2680979bb6cbb1e456f876.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d4e7eed807c2b20492caac0a62c4d6c3.webp",980,1268]